| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
disease | 0.100 | None | 1.000 | 5 | 27 | 2007 | 2013 | |||||||||
|
testis expressed basic protein 1 | 0.638 | 0.692 | 1.5E-16 |
|
disease | 0.100 | None | 1.000 | 4 | 17 | 2007 | 2012 | ||||||||
|
cytochrome P450 family 21 subfamily A member 2 | 0.525 | 0.769 | 2.6E-04 |
|
disease | 0.100 | None | 1.000 | 2 | 12 | 2007 | 2010 | ||||||||
|
major histocompatibility complex, class II, DR alpha | 0.581 | 0.769 | 0.52 |
|
disease | 0.440 | None | 1.000 | 2 | 10 | 1999 | 2010 | ||||||||
|
major histocompatibility complex, class II, DR beta 9 (pseudogene) | 0.682 | 0.654 |
|
disease | 0.100 | None | 1.000 | 2 | 6 | 2007 | 2010 | |||||||||
|
butyrophilin like 2 | 0.546 | 0.808 | 8.6E-11 |
|
disease | 0.110 | None | 1.000 | 2 | 6 | 2006 | 2013 | ||||||||
|
psoriasis susceptibility 1 candidate 1 | 0.656 | 0.731 | 2.7E-04 |
|
disease | 0.100 | None | 1.000 | 1 | 6 | 2007 | 2007 | ||||||||
|
major histocompatibility complex, class I, F | 0.631 | 0.654 | 3.3E-05 |
|
disease | 0.100 | None | 1.000 | 2 | 5 | 2007 | 2009 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.200 | None | 1.000 | 2 | 5 | 1979 | 2019 | ||||||||
|
C-type lectin domain containing 16A | 0.612 | 0.654 | 0.28 |
|
disease | 0.500 | None | 1.000 | 2 | 5 | 2009 | 2020 | ||||||||
|
major histocompatibility complex, class II, DQ beta 2 | 0.573 | 0.731 | 4.3E-02 |
|
disease | 0.100 | None | 1.000 | 1 | 5 | 2007 | 2007 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 2 | 0.617 | 0.769 | 1.0E-05 |
|
disease | 0.110 | None | 1.000 | 1 | 5 | 1989 | 2007 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.500 | None | 0.985 | 4 | 4 | 1994 | 2019 | ||||||||
|
HLA-F antisense RNA 1 | 0.861 | 0.269 |
|
disease | 0.100 | None | 1.000 | 2 | 4 | 2007 | 2009 | |||||||||
|
HLA complex group 22 (gene/pseudogene) | 0.736 | 0.423 |
|
disease | 0.100 | None | 1.000 | 1 | 4 | 2007 | 2007 | |||||||||
|
POU class 5 homeobox 1 | 0.441 | 0.846 | 0.95 |
|
disease | 0.100 | None | 1.000 | 1 | 4 | 2007 | 2007 | ||||||||
|
solute carrier family 44 member 4 | 0.678 | 0.615 | 1.0E-14 |
|
disease | 0.100 | None | 1.000 | 1 | 4 | 2010 | 2010 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.200 | None | 1.000 | 3 | 3 | 2004 | 2020 | ||||||||
|
BTB domain and CNC homolog 2 | 0.539 | 0.731 | 1.00 |
|
disease | 0.110 | None | 1.000 | 2 | 3 | 2011 | 2013 | ||||||||
|
tenascin XB | 0.572 | 0.731 | 1.9E-02 |
|
disease | 0.100 | None | 1.000 | 2 | 3 | 2007 | 2010 | ||||||||
|
euchromatic histone lysine methyltransferase 2 | 0.590 | 0.808 | 1.0E-04 |
|
disease | 0.100 | None | 1.000 | 2 | 3 | 2007 | 2010 | ||||||||
|
notch receptor 4 | 0.534 | 0.731 | 2.1E-23 |
|
disease | 0.130 | None | 1.000 | 2 | 3 | 2004 | 2013 | ||||||||
|
zinc finger MIZ-type containing 1 | 0.588 | 0.615 | 1.00 |
|
disease | 0.110 | None | 1.000 | 2 | 3 | 2011 | 2019 | ||||||||
|
major histocompatibility complex, class II, DM beta | 0.638 | 0.615 | 2.5E-03 |
|
disease | 0.110 | None | 1.000 | 1 | 3 | 1999 | 2007 | ||||||||
|
major histocompatibility complex, class II, DM alpha | 0.608 | 0.654 | 2.4E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 3 | 2007 | 2007 |